Outcomes “Remain Poor” in Children With Non-Rhabdomyosarcoma Soft Tissue Sarcoma

Children and young adults with metastatic non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) continue to have “poor” survival outcomes despite the use of adaptive ifosfamide plus doxorubicin-based multimodal therapy, according to research published in the Journal of the National Cancer Institute.

Read more: https://www.cancertherapyadvisor.com/news/outcomes-poor-children-non-rhabdomyosarcoma-soft-tissue-sarcoma/